| 000 | 01796 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250514210501.0 | ||
| 264 | 0 | _c20050517 | |
| 008 | 200505s 0 0 eng d | ||
| 022 | _a0268-3369 | ||
| 024 | 7 |
_a10.1038/sj.bmt.1704756 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMohty, M | |
| 245 | 0 | 0 |
_aThalidomide salvage therapy following allogeneic stem cell transplantation for multiple myeloma: a retrospective study from the Intergroupe Francophone du Myélome (IFM) and the Société Française de Greffe de Moelle et Thérapie Cellulaire (SFGM-TC). _h[electronic resource] |
| 260 |
_bBone marrow transplantation _cJan 2005 |
||
| 300 |
_a165-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGraft vs Host Disease |
| 650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMultiple Myeloma _xmortality |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aSalvage Therapy _xmethods |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 |
_aThalidomide _xadministration & dosage |
| 650 | 0 | 4 | _aTransplantation, Homologous |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aAttal, M | |
| 700 | 1 | _aMarit, G | |
| 700 | 1 | _aBulabois, C E | |
| 700 | 1 | _aGarban, F | |
| 700 | 1 | _aGratecos, N | |
| 700 | 1 | _aRio, B | |
| 700 | 1 | _aVernant, J P | |
| 700 | 1 | _aSotto, J J | |
| 700 | 1 | _aCahn, J Y | |
| 700 | 1 | _aBlaise, D | |
| 700 | 1 | _aJouet, J P | |
| 700 | 1 | _aFacon, T | |
| 700 | 1 | _aYakoub-Agha, I | |
| 773 | 0 |
_tBone marrow transplantation _gvol. 35 _gno. 2 _gp. 165-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bmt.1704756 _zAvailable from publisher's website |
| 999 |
_c15219466 _d15219466 |
||